HRMY Harmony Biosciences Holdings, Inc.
8-K Current Report
Filed: February 24, 2026
Health Care
Pharmaceutical PreparationsHarmony Biosciences Holdings, Inc. (HRMY) 8-K current report filed with SEC EDGAR on February 24, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items2 items
- Item 2.02: Results of Operations and Financial Condition
- Item 7.01: Regulation FD Disclosure
AI Filing Analysis8-K
Item 2.02 · Results of Operations and Financial Condition
- • Q4 and full-year 2025 earnings reported Feb 24, 2026 — see Exhibit 99.1 for detailed financials
- • Results cover quarter and year ended Dec 31, 2025
Item 7.01 · Regulation FD Disclosure
- • Harmony Biosciences posted an investor presentation on Feb 24, 2026 to its IR website for use in analyst/investor meetings
- • Presentation is "furnished" not "filed" — not subject to Exchange Act Section 18 liability, limiting investor recourse
Get deeper insights on Harmony Biosciences Holdings, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.